Human Basophils and Cytokines/Chemokines  by Yamaguchi, Masao et al.
Allergology International Vol 58, No1, 2009 www.jsaweb.jp 1
Human Basophils and Cytokines
Chemokines
Masao Yamaguchi1, Rikiya Koketsu1, Maho Suzukawa1,2, Ayako Kawakami1 and Motoyasu Iikura3
ABSTRACT
Basophils comprise the smallest population in human peripheral blood leukocytes. The role of basophils in the
pathogenesis of allergic diseases has long been obscure, although their accumulation and activation in tissues
have suggested their potential importance. Recent advances in the field of basophil biology have indicated that
cytokines and chemokines are the primary regulators of basophil functions. In addition, various functions of
these cells seem differently modulated. The evidence strongly supports the notion that basophils exposed to
these substances and allergens will behave as unique effector cells that presumably play proinflammatory roles
in type I allergic reactions.
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INTRODUCTION
Basophils are the least abundant cell type among hu-
man peripheral blood leukocytes. They have a high
affinity receptor for IgE (FcεRI) on their surface, and
cross-linking of IgE molecules by specific antigens or
anti-IgE antibodies, or ligation of FcεRI molecules by
anti-FcεRI antibodies, leads to the liberation of pre-
formed mediators such as vasoactive amines. Baso-
phil activation also results in de novo synthesis of lipid
mediators such as LTC4, in addition to cytokines in-
cluding IL-4 and IL-13. Through release of these me-
diators and cytokines, basophils are thought to be ac-
tive participants in the pathogenesis of IgE-mediated
allergic inflammation.1,2
Several lines of evidence have suggested that baso-
phils represent important effector cells in the patho-
genesis of allergic late-phase reactions. Local accu-
mulation of these cells is observed at sites of nasal
and cutaneous late-phase reactions,3,4 and it is re-
ported that late-phase nasal secretions and bronchoal-
veolar lavage fluid contain a cell population which is
morphologically identified as basophils.5,6 In addition,
analysis of the local chemical mediator profile in na-
sal secretions has indicated that basophils may be a
significant source of the mediators in late-phase reac-
tions.4,7 Recently, Karasuyama et al. elegantly
showed that basophils are a critically important
player in the pathogenesis of IgE-mediated very-late-
phase allergic responses and IgG-mediated anaphy-
lactic reactions in mice8-10 (also see the article by
Karasuyama appearing in this issue).
Although the precise mechanisms of basophil accu-
mulation and activation in local tissues of antigen-
induced allergic inflammation and chronic allergic
diseases such as asthma remain unclear, it is thought
that there must be an active pathway that attracts and
stimulates basophils, since those cells usually reside
in circulating blood. Basophils are motile cells, and
they seem to have a sophisticated sensor system rela-
tive to their surrounding environment.11,12 In a series
of analyses of basophils’ biological functions, we have
identified certain cytokines and chemokines as poten-
tially important regulators that act on them. Interest-
ingly, these biologically potent regulators modulate
various arrays of basophil functions. In this article, we
discuss how each function of basophils is regulated
by cytokines and chemokines. And, in the last sec-
tion, we describe our recent findings that a new cy-
tokine of the IL-1 family, IL-33, is able to regulate di-
verse basophil functions.
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Fig. 1 Expression profiles of IL-3Rα, IL-5Rα, and GM-
CSFRα in basophils vs. eosinophils.20 (A) The expression 
levels of mRNA of IL-3Rα, IL-5Rα, and GM-CSFRα in baso-
phils (n＝5) and eosinophils (n＝5). Data are expressed as 
the copy number ratio against β-actin. (B) The surface pro-
tein expression levels of IL-3Rα, IL-5Rα, and GM-CSFRα 
on basophils (n＝8) and eosinophils (n＝8). Data are ex-
pressed as ΔMESF values calculated using the folowing 
formula: (MESF of cels stained with specific mAb) - (MESF 
of cels stained with control IgG). MESF: molecules of 
equivalent soluble fluorochrome unit.
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ACTIVATION
Accumulated evidence indicates that IL-3 is the most
potent activator of mature human basophils. Al-
though IL-3 is capable of inducing direct histamine
release from basophils in a small and selected subset
of atopic patients, it potentiates basophil degranula-
tion in almost all normal as well as atopic individuals.
Short-term (15 min) pretreatment of basophils with
IL-3 results in marked enhancement of histamine re-
lease initiated by anti-IgE, formylmethionyl-leucyl-
phenylalanine (FMLP), calcium ionophore A23187
and phorbol ester.13-15 IL-3 also renders basophils
susceptible to stimulation with secretory IgA, comple-
ment C3a or platelet-activating factor (PAF), which
alone are unable to transduce signals sufficient for ba-
sophil degranulation.16-18
Granulocyte-macrophage colony-stimulating factor
(GM-CSF) and IL-5 also enhance histamine releas-
ability from basophils. Based on inspection of the
ED50 values, IL-3 exerted the most potent priming ef-
fects (ED50: 0.3 and 1 pM for anti-IgE- and FMLP-
induced degranulation, respectively), while IL-5 and
GM-CSF were～30-fold less active compared with IL-
3.13,19,20 The difference in basophil sensitivity to the
cytokines may reflect the varied receptor levels (Fig.
1A, B).20 However, the maximal responses at the opti-
mal doses of IL-5 and GM-CSF were equivalent to
those induced by IL-3.
Insulin-like growth factor (IGF)-I enhanced hista-
mine release initiated by anti-IgE, calcium ionophore
A23187 and phorbor ester.21 Stem cell factor (SCF)
also weakly enhanced degranulation triggered by
some, but not all, secretagogues.22-24 Interestingly,
IGF-I and SCF co-operatively enhanced surface ex-
pression of an activation marker, CD69, on baso-
phils.24 IL-1, interferon (IFN)-γ, and nerve growth fac-
tor (NGF), but not IL-4, tumor necrosis factor (TNF)-
α, or transforming growth factor (TGF)-β, can also
enhance basophil degranulation.11
Several studies, including ours, have shown that
prolonged incubation with IL-3 profoundly affects ba-
sophil releasability. For example, basophils from 10
to 20% of donors completely fail to release histamine
in response to anti-IgE, and such donors are called
nonreleasers.25,26 Long-term culturing (>3 d) with IL-
3 results in these basophils becoming able to release
histamine in response to anti-IgE or specific anti-
gen.27,28 Detailed intracellular signal analysis indi-
cated that a defect in the tyrosine kinase Syk ac-
counts for the lack of basophil response to IgE
crosslinking stimulus in those donors, and that the
defect is corrected after >3 days of culture with IL-3.29
IL-3 is also known to enhance the secretion of de
novo synthesized mediators such as LTC4. At pico-
molar concentrations, short-term preincubation with
IL-3 primes basophils for enhanced LTC4 secretion
after challenge with anti-IgE or FMLP.14 Basophils
are reported to be an important source of Th2 cytoki-
nes, including IL-4 and IL-13; 30-32 although short-
term pretreatment with IL-3 (30 min) does not affect
IL-4 release from basophils, long-term incubation
with IL-3 (18 h) results in a marked increase in IL-4
secretion.
In addition to their chemotactic activities on leuko-
cytes, chemokines are able to directly activate baso-
phils. As demonstrated by us and others, MCP-1
CCL2 was the most potent secretagogue among
chemokines.33,34 MCP-1 induced approximately 20%
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of histamine release from freshly isolated basophils,
which was apparently amplified by priming with IL-
3.35 IL-8CXCL8 elicited weak degranulation from ba-
sophils, which was also enhanced by IL-3 pretreat-
ment. On the other hand, freshly isolated basophils
did not degranulate significantly in response to SDF-
1CXCL12, MIP-1αCCL3 or MIP-1βCCL4 in our
study.35
We recently reported that basophils, retrieved by
bronchoalveolar lavage from patients with asthma,
showed elevated levels of surface CD69 compared to
the patients’ peripheral blood basophils, and that
strong induction of surface CD69 expression occurs
in vitro in the presence of relatively high doses of IL-
3.20,36 This was in clear contrast to the finding that
other surface molecules on basophils such as CD44
or CD54 failed to demonstrate differences between
healthy and asthmatic subjects. Thus, CD69 was
thought to be a useful marker for basophil activation,
with potential clinical relevance, although we failed to
observe any functional significance for basophil
CD69. We previously reported that expression of
CD69 by basophils was preferentially upregulated by
IL-3. CD69 analysis using basophils cultured for 24 h
with various concentrations of cytokines showed that
expression of CD69 required considerably large
amounts of IL-3 (ED50: 50 pM), whereas even as large
as nanomolar orders of either IL-5 or GM-CSF in-
duced only marginal levels of CD69 expression.20 In-
terestingly, very low doses of antigen or anti-FcεRIα
chain mAb (CRA-1) (1 ngml) clearly enhanced baso-
phil CD69 expression in the presence of IL-3; such
concentrations of antigen or CRA-1 mAb correspond
to subthreshold doses for triggering degranulation of
basophils.37
RT-PCR analysis demonstrated that basophils pos-
sessed transcripts for several Toll-like receptors
(TLR), such as TLR4, TLR2, TLR9 and TLR10. Vari-
ous TLR ligands were tested on freshly isolated baso-
phils, but no functional changes were detected. After
incubation of basophils with IFN-γ, a TLR4 ligand
lipopolysaccharide slightly upregulated CD11b ex-
pression on basophils.38,39
ADHESION
Several lines of evidence indicate that IL-3 is involved
in the regulation of basophil adherence to vascular
endothelial cells. As reported by Bochner et al., IL-3
stimulates in vitro adherence of basophils to vascular
endothelial cells.40 And their enhanced adherence
was thought to be mediated by upregulation of sur-
face β2 integrin (CD11bCD18) expression. We
found that not only IL-3 but also other hemopoietic
growth factors, i.e., IL-5 and GM-CSF, up-regulated
CD11b expression on basophils.20 The receptors for
these cytokines are known to share a common β
subunit as a signal-transducing apparatus, but the po-
tency of the three cytokines in enhancing CD11b ex-
pression was not equal. IL-3 was the strongest in-
ducer of surface CD11b, and half-maximal induction
was obtained at as low as 6 pM of IL-3. IL-5 and GM-
CSF were less potent compared to IL-3, and～10-fold
higher doses of these two cytokines were necessary
for significant induction of CD11b expression on ba-
sophils. In a recent study analyzing basophil rolling
and adhesion under physiological shear flow condi-
tions, P-selectin and β1 integrins (CD49d and
CD49eCD29) on basophils were involved in both
rolling and adhesion on IL-3-treated endothelial
cells.41
MIGRATION
In previous studies using a modified Boyden cham-
ber and polycarbonate membrane with 5-μm pores,
serially diluted hemopoietic growth factors were
tested for basophil migratory activity.42,43 We found
that GM-CSF, IL-3 and IL-5 had marked effects on ba-
sophil locomotion: the maximal numbers of migrated
basophils increased to more than 10 times the back-
ground levels. GM-CSF was slightly more potent than
IL-3 and IL-5. Checkerboard analyses indicated that
these cytokines had mainly chemokinetic rather than
chemotactic effects.
We next examined the expression profile of a panel
of chemokine receptors in basophils, and found that
basophils expressed transcripts of CCR1, CCR2,
CCR3, CCR5, CXCR1, CXCR2 and CXCR4.35,44
Among 16 chemokines tested, eotaxinCCL11 in-
duced the most potent basophil migration. In addi-
tion, migration of basophils toward eotaxin was en-
hanced by very weak FcεRI-crosslinking stimulus,
CRA-1 mAb at 1 ngml.45 SDF-1 also induced a
strong, migratory response comparable to that in-
duced by eotaxin in 24-h cultured basophils, reflect-
ing CXCR4 expression induced during culture.35,46
SDF-1 did not elicit any calcium influx in freshly iso-
lated basophils but caused strong influx in 24-h cul-
tured basophils. Similar to as we already demon-
strated for eosinophils,47,48 expression of CXCR4 on
basophils was also regulated by several cytokines: it
was markedly suppressed by IL-3 and slightly sup-
pressed by GM-CSF, IL-5 and IL-4. However, IFN-γ,
TGF-β and TNF-α each had no effect on basophil
CXCR4 expression. CXCR4 expression on basophils
was highly sensitive to IL-3, a femtomolar order of
which was sufficient for inhibition of the expres-
sion.35
TRANSENDOTHELIAL MIGRATION (TEM)
We have established a basophil TEM assay using hu-
man basophils and Transwell systems (Costar, Cam-
bridge, MA, USA) with cultivated human umbilical
vein endothelial cells (HUVEC) on the surface.49 HU-
VEC were activated by stimulation with IL-1β for 4 h
before performing assays.
Figure 2 depicts the effects of various chemokines
Yamaguchi M et al.
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Fig. 2 Efects of various chemokines on basophil transen-
dothelial migration (TEM).49 HUVEC were pretreated with IL-
1β (5 ng/ml) at 37°C for 4 h. TEM assay was performed in 
the presence of various chemokines at the indicated concen-
trations in the lower wels. Basophils were semi-purified by 
Percol density centrifugation from peripheral blood, and im-
mediately added to the upper wels. After 3 h of incubation 
at 37°C, the cels in the lower wels were colected, and the 
number of IgE-positive cels was determined by flow 
cytometry. Percentages of migrated basophils are shown, 
based on the total numbers of cels inoculated into the upper 
wels. Bars represent the SEM (n＝4―7).
＊P ＜ 0.05, ＊＊P＜ 0.01, vs. migration in the absence of 
chemokines.
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on TEM of Percoll-separated human basophils.49
Highly purified basophil preparations after Percoll
and MACS separation gave essentially the same re-
sults. TEM was determined after 3 h of incubation us-
ing IL-1β-activated HUVEC. Among the various
chemokines tested, CCR3 ligands, eotaxinCCL11
and RANTESCCL5 induced strong basophil TEM.
Eotaxin binds specifically and exclusively to CCR3,
whereas RANTES binds to both CCR1 and CCR3, al-
though with higher affinity for CCR1. To determine
the chemokine receptors responsible for RANTES-
induced basophil TEM, we next performed blocking
experiments using receptor-specific mAbs. As ex-
pected, eotaxin-induced TEM was almost completely
inhibited by anti-CCR3 mAb. Although RANTES-
induced TEM was also markedly blocked by anti-
CCR3 mAb, treatment with anti-CCR1 mAb exerted
virtually no effect, suggesting that CCR3 is the re-
sponsible receptor mediating the transmigratory re-
sponse for both eotaxin and RANTES. This is also in-
teresting in that it is the reverse of the relative affini-
ties of RANTES for these two receptors, indicating
that the affinity and TEM inducing activity of RAN-
TES are not equivalent. Moreover, there was yet an-
other chemokine receptor which induced basophil
TEM: SDF-1, a specific ligand for CXCR4. Although
freshly isolated basophils failed to exhibit TEM in re-
sponse to SDF 1, strong TEM was observed with 24-h
cultured basophils. In parallel to our previous find-
ings regarding basophil chemotaxis,35 these results
show that both CCR3 and CXCR4 are involved in ba-
sophil TEM. We found that β2 integrin is the key ad-
hesion molecule that mainly accounts for basophil
TEM. β1 integrin is also slightly involved, since TEM
of fresh basophils toward eotaxin or IL-3 was signifi-
cantly suppressed by treatment of basophils with anti-
CD18 mAb, and weakly suppressed by anti-CD29
mAb.49
The involvement of IL-3 was also assessed in that
study.49 When no chemokines were added to the
lower wells, a significant increase in basophil TEM
was observed when the cell suspension in the upper
wells contained as low as 3 pM of IL-3. Furthermore,
IL-3 showed an additive effect on eotaxin-directed
TEM: the number of basophils that transmigrated to-
ward eotaxin was significantly increased in the pres-
ence of IL-3. However, the magnitude of IL-3’s effect
on basophil TEM was modest compared to the strong
effect of eotaxin.
TRANS-BASEMENT MEMBRANE MIGRA-
TION
Basophil trans-basement membrane migration assay
was performed using an experimental model, Ma-
trigel (BD Biosciences, Bedford, MA, USA),50 a gel
containing basement membrane components, i.e.,
laminin, type IV collagen, heparan sulfate, proteogly-
can and entactin.51 Various chemokines were placed
in the lower chamber. After 18 h of incubation, ap-
proximately 10 to 16% of the basophils had transmi-
grated spontaneously to the lower chamber. How-
ever, no apparent induction of transmigration was ob-
served with any of the tested chemokines (“Nil” col-
umns in Fig. 3A), showing a clear contrast to the find-
ings for basophil TEM,49 in which cells actively trans-
migrated towards certain chemokines. We next in-
cluded the potent basophil-active cytokine, IL-3, at
300 pM in the upper chamber. As shown in Figure 3A
(“IL-3” columns), IL-3 induced statistically significant
basophil trans-basement membrane migration even
in the absence of chemoattractants in the lower
chambers. Moreover, among the chemokines tested,
IL-8 and RANTES added to the lower chambers at 50
nM induced a significant increase in migration com-
pared to the spontaneous migration of IL-3-treated ba-
sophils. Other chemokines, including MCP-1 and eo-
taxin, exhibited weak basophil attracting potency, but
it did not reach statistical significance. Another well-
Human Basophils and CytokinesChemokines
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Fig. 3 Efects of chemokines on trans-basement membrane migration of 
human basophils.51 (A) Percol-separated basophils were suspended in 
medium with (filed columns) and without (open columns) IL-3 at 300 pM 
and subjected to the basophil trans-Matrigel migration assay. Various che-
mokines or complement C5a were placed in the lower chamber. After incu-
bation for 18 h, cels that had migrated to the lower chambers were 
counted by flow cytometry. The percentage of migrated cels was calcu-
lated by subtracting the spontaneous migration of IL-3-untreated cels 
(14.0±3.6% for medium only). Bars represent the SEM (n＝5). ＊P＜0.05 
and ＊＊P＜0.01. (B) Basophils were preincubated with anti-CCR mAb (20 
μg/ml) or isotype control mAb (mouse IgG1, 20 μg/ml), or anti-CXCR mAb 
(1 μg/ml) or isotype control mAb (mouse IgG2a, 1 μg/ml) at 37℃ for 60 
min, and the transmigration assay was performed in the presence of RAN-
TES or IL-8 at 50 nM in the lower chamber and IL-3 at 300 pM in the upper 
chamber. Bars represent the SEM (n＝5). ＊＊P＜0.01 and ＊＊＊P＜0.001 
vs. migrated cels pretreated with control antibody. The percent migration 
of basophils pretreated with control antibody was 56.4±10.5% (RANTES) 
and 35.5±5.8% (IL-8).
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known chemoattractant for basophils, complement
C5a, failed to show significant transmigration-
inducing activity. On the other hand, among the lipid
mediators tested, 5-oxo-ETE and PAF at 1 μM signifi-
cantly induced basophil transmigration, but only
when IL-3 was included in the upper chamber (data
not shown). Thus, the repertoire of attracting sub-
stances involved in this basophil transmigration sys-
tem was unique compared to that in TEM or simple
migration. Blocking experiments clearly demon-
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strated that both CCR1 and CCR3 were involved in
the RANTES-directed trans-basement membrane mi-
gration of basophils, and that CXCR1, but not CXCR2,
was involved in the case of IL-8 (Fig. 3B).51 These re-
sults showed that not only CCR3 but also two other
chemokine receptors, CCR1 and CXCR1, are involved
in this transmigration across Matrigel. Anti-CD18
mAb but not anti-CD29 significantly inhibited IL-3
plus RANTES-induced transmigration, indicating that
β2 integrin, but not β1 integrin, plays a central role in
trans-Matrigel migration of basophils.
Importantly, IL-3 was essential for chemoattractant-
induced transmigration, since, in the absence of IL-3,
none of the tested chemokines upregulated basophil
transmigration above the control level. In addition, an
elastase inhibitor that blocks certain matrix metallo-
proteinases (MMPs) obviously attenuated transmi-
gration of basophils. The results of quantitative real-
time PCR and immunohistochemical studies sug-
gested that MMP-9 is synthesized, stored in the cyto-
plasm, expressed on the cell surface and released by
basophils, and flow cytometric analysis indicated that
IL-3 upregulated surface MMP-9 levels on baso-
phils.51 Presumably the effects of IL-3 on the expres-
sion of both β2 integrin and MMP-9 are importantly
involved in the transmigration: cell-surface MMP-9
andor MMP-9 that has been released will coopera-
tively help basophils expressing enhanced levels of
β2 integrin cross the basement membrane.
SURVIVAL
It was already reported that IL-3 maintained the vi-
ability of purified basophils during culture.52 In the
absence of cytokines, basophils rapidly died, and sur-
vived in vitro for only 3 days. Addition of IL-3 resulted
in marked enhancement of basophil survival, such
that nearly half of the cells remained viable for 14
days, as assessed by trypan blue stain. Several years
after that initial study, the anti-apoptotic potencies of
cytokines were analyzed by flow cytometry.20,53 As
judged by their plateau levels, IL-5 and GM-CSF were
equally effective with IL-3 in protecting basophils
from apoptosis. The rank order of potency as as-
sessed by the ED50 values was IL-3 > IL-5 = GM-CSF,
with IL-3 being ～10-fold more potent than the oth-
ers. It should be noted that even a very low concen-
tration of IL-3 was sufficient for survival enhancement
(ED50: 20 fM). IFN-γ is also reported to enhance ba-
sophil survival, but IL-4 or TNF-α is not.11 On the
other hand, SCF, in concert with IL-3, was shown to
prolong survival of basophils.23
A glucocorticoid, dexamethasone, is known to in-
duce apoptosis in basophils. To determine whether
IL-3 can overcome the apoptosis-inducing effect of
dexamethasone, basophils were incubated with seri-
ally diluted IL-3 in the presence and absence of dex-
amethasone (100 nM).53 The enhanced life span in-
duced by low concentrations of IL-3 (300 fM) was
clearly shortened by dexamethasone, with statistical
significance. On the other hand, dexamethasone ex-
erted no significant effect on the rate of basophil
apoptosis in the presence of higher concentrations of
IL-3 (3 ― 300 pM). Similar results were observed for
the relationships between the effects of IL-3 and
basophil-apoptotic substances other than glucocorti-
coids.54
EFFECT OF A NEW CYTOKINE, IL-33 ON
ADHERENCE AND ACTIVATION OF BASO-
PHILS
IL-33 is a recently identified cytokine that belongs to
the IL-1 family.55 This cytokine binds to the ST2 re-
ceptor (also called DER4, Fit-1 or T1), which has high
homology to IL-1 receptor.55 ST2 receptor is reported
to be expressed on mast cells56 and Th2 cells,57 but
not on Th1 cells. ST2 has been considered to mediate
the biological action of its ligand, IL-33, which can
cause Th2-biased allergic inflammation. Accumulat-
ing evidence suggests that IL-33 can exert significant
biological effects both in vivo and ex vivo.55,57-59 For
example, IL-33 enhances production of Th2-
associated cytokines by in vitro polarized Th2 cells.
In addition, in mast cells, we recently demonstrated
that IL-33 enhanced the survival of human umbilical
cord blood-derived mast cells and promoted their ad-
hesion to fibronectin as well as their production of IL-
8 and IL-13.60 IL-33 is now recognized as a potentially
important cytokine that enhances Th2-balanced im-
mune regulation, but the action of IL-33 on allergic ef-
fector cells had not been known until recently.
In our very recent study analyzing the effects of IL-
33 on human basophils, we demonstrated that baso-
phils express the transcript and protein for ST2, a re-
ceptor for IL-33. IL-33 affected several arrays of baso-
phil functions: this cytokine upregulated CD11b ex-
pression on the cell surface of basophils, enhanced
eotaxin-directed chemotaxis, induced Th2 cytokine
IL-4 secretion and augmented the IgE-mediated hista-
mine release reaction.61 Importantly, basophil adhe-
sion was potently enhanced by IL-33, and this action
of IL-33 was stronger than that of IL-3, a well-known
basophil-active cytokine. Neutralization experiments
demonstrated that ST2 mediates IL-33’s effects on ba-
sophils. In other studies analyzing the actions of IL-
33, we found that this cytokine also activates human
eosinophils.62 However, the precise effects of IL-33 on
eosinophils differ somewhat from those on basophils:
IL-33 failed to enhance migration and degranulation
of eosinophils but suppressed eosinophil apoptosis,61
whereas basophil apoptosis was not affected by IL-33.
The different spectra of IL-33’s effects on basophils
and eosinophils may in part account for the different
behaviors and fates of these effector cells in the con-
trolling mechanisms of allergic inflammation.
These findings suggest that IL-33 may be a potent
and unique regulator acting not only on lymphocytes
Human Basophils and CytokinesChemokines
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Fig. 4 Cytokines and chemokines afect human basophils. Representative cytokines and 
chemokines that either enhance or directly trigger various functions of these cels are 
described. TEM: transendothelial migration. TBMM: trans-basement membrane migration.
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or mast cells, but also on effector cells such as baso-
phils and eosinophils.61-64 Further studies assessing
the precise roles of IL-33 in various allergic diseases
will be important.
CONCLUSION
Basophils constitute the smallest subpopulation of
leukocytes, but they seem to be powerful cells capa-
ble of secreting various bioactive mediators in tissues
and in the blood, where they encounter allergens
andor their affecting cytokineschemokines. In hu-
man peripheral blood, basophil density is strictly
regulated: the percentage of basophils among total
peripheral leukocytes usually does not exceed 2%. Af-
ter undergoing maturation steps in the bone marrow,
basophils enter the blood stream. After a rather short
(hours to days) stay in the circulating blood, baso-
phils are thought to be trapped in tissues with ele-
vated levels of attracting molecules (Fig. 4). Although
several features, such as metachromatic stain, hista-
mine content and surface expression of FcεRI, indi-
cated great similarities between basophils and mast
cells, these two cell types are not very close in origin.
Mast cells reside in the bone marrow only during the
initial steps of their differentiation; mast cell progeni-
tors enter the blood and then move into tissues
where they proliferate and mature.10 Now we believe
that eosinophils show a closer association with baso-
phils; the mechanisms regulating differentiation
maturation of these cells are quite similar.11 We thus
think that the detailed analyses of the biological func-
tions of mature basophils and eosinophils focusing on
cytokines and chemokines, as presented in this
manuscript, are important. Interestingly, these sub-
stances discussed in this manuscript are also known
to be important regulators of mature eosinophil func-
tions,11,65 and the repertoires of cytokineschemoki-
nes acting on basophil and eosinophil functions are
mostly overlapping. For example, a CCR3 ligand, eo-
taxin, is a very potent chemoattractant for both baso-
phils and eosinophils freshly isolated from peripheral
blood.
However, in our studies, we have also found that
the actions of cytokines and chemokines on basophils
are not identical to those on eosinophils. Of course,
substances that either modify or directly induce baso-
phil degranulation cannot be theoretically extrapo-
lated to eosinophils, since eosinophils do not manifest
rapid degranulation. It has long been known that,
among the three hemopoietic growth factors, IL-3, IL-
5 and GM-CSF, IL-3 most potently activates various
types of basophil functions, whereas IL-5 efficiently
activates eosinophils. Their differences have so far
been explained on the basis of the levels of their re-
ceptor expression in these cells. IL-3 receptor α chain
(IL-3Rα) mRNA is abundantly expressed in baso-
phils, but in eosinophils IL-5Rα mRNA is dominant
among the α chains of the three cytokines (Fig. 1).20
Thus, the receptor expression levels may be an im-
portant factor that determines the sensitivity and
magnitude of the cells’ responses to each cytokine
chemokine. The expression levels of cytokine
chemokine receptors are not always stable; transient
or inducible expression of receptors will significantly
Yamaguchi M et al.
8 Allergology International Vol 58, No1, 2009 www.jsaweb.jp
modify the actions of basophils at inflammatory sites.
For example, basophil CXCR4 expression is strongly
induced during culture for a few hours or one day,
and basophils acquire responsiveness to the ligand,
SDF-1, during culture.35 Interestingly, basophil
CXCR4 expression is almost completely suppressed
by IL-3, and cells exposed continuously to IL-3 pre-
sumably retain relatively low sensitivity to SDF-1. In
addition, IL-33 enhances basophil expression of the
IL-33 receptor, ST2, and these cells, having been
once exposed to IL-33, may maintain their response
to this cytokine.61
Recent progress, especially regarding the in vivo
roles of basophils, has greatly increased the attention
paid to this small leukocyte subpopulation. Moreover,
in this context, clarification of basophil-unique
mechanisms will provide us with important insights
into disease pathogenesis. Such information will, in
turn, contribute to our understanding of the patho-
genesis of various allergic diseases, including asthma
and anaphylaxis, in which basophils (and eosino-
phils) play significant roles. Future studies analyzing
these issues can also be expected to provide us with
important clues that will be useful for establishing
novel therapeutic strategies.
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